Ophthalmic composition containing sulfasalazine and hyaluronic acid
US11077125B2 · kind B2 · utility
0Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 2017 |
| Grant date | Aug 3, 2021 |
| Priority date | — |
| Expiry date | Dec 15, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An ophthalmic composition containing sulfasalazine and hyaluronic acid is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.